Aurora Cannabis Inc. (ACB)

Tilray Brands Sinks 4% as Record Revenue Masks Shrinking Cannabis Sales; Canopy Growth and Aurora Cannabis Ease

Aurora Completes Major Expansion of European EU-GMP Manufacturing Facility, More Than Doubling Expected Annual Flower Output

Aurora Urges Shareholders to Take No Action to Revised Hostile Bid by Curaleaf as Formal Review Underway

Curaleaf's Higher Aurora Bid Raises the Stakes in Cannabis Consolidation

Aurora Maintains Shareholder Recommendation to Take No Action at this Time as Curaleaf Has Yet to File Their Revised Hostile Bid

Aurora Cannabis (TSE:ACB) Shares Up 15.6% – Still a Buy?

Aurora Cannabis Sees Unusually High Options Volume (NASDAQ:ACB)

Curaleaf raises Aurora Cannabis offer by 25%

Comparing ProPhase Labs (NASDAQ:PRPH) and Aurora Cannabis (NASDAQ:ACB)

Curaleaf's Hostile Takeover Attempt of Aurora Cannabis Is Hitting Turbulence. Here's What Investors Should Watch.

Aurora Cannabis Files Application with Alberta Securities Commission to Protect Company Shareholders Having Identified Several Deficiencies in Curaleaf's Hostile Bid Disclosure

Aurora Cannabis Provides Business Update; Accretive Acquisition of Safari Flower Company and Leading European Performance Expected to Fuel International Growth in the Fiscal Second Quarter 2027 and Beyond

Curaleaf Tries To Roll Up Aurora In a Hostile Cannabis Bid

Aurora Cannabis Refutes Curaleaf's Latest Attempt To Distract Shareholders From The Facts

Aurora Cannabis Refutes Curaleaf's Latest Attempt To Distract Shareholders From The Facts

$250,000 in These 3 High-Income ETFs Could Pay You ~$2,800 a Month

Aurora Appoints Seasoned Biopharmaceutical Executive to Lead Commercial Acceleration of Global Medical Cannabis Business

Curaleaf Responds to Aurora Circular; Reaffirms Offer as the Best Path to Value Creation for Shareholders

Aurora Cannabis Calls Curaleaf Offer Inadequate, Urges Rejection

Aurora Cannabis Urges Shareholders to REJECT Curaleaf's Hostile Bid, Warning that it is Inadequate, Undervalues Aurora and Puts Shareholder Value and Future Upside at Risk